Medipost Co (Medipost Co) Additional Paid-In Capital : $207.42 Mil(As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medipost Co Additional Paid-In Capital?

Medipost Co's quarterly additional paid-in capital increased from Sep. 2023 ($158.82 Mil) to Dec. 2023 ($211.76 Mil) but then stayed the same from Dec. 2023 ($211.76 Mil) to Mar. 2024 ($207.42 Mil).

Medipost Co's annual additional paid-in capital increased from Dec. 2020 ($117.85 Mil) to Dec. 2021 ($133.85 Mil) but then declined from Dec. 2021 ($133.85 Mil) to Dec. 2022 ($122.51 Mil).

Medipost Co Additional Paid-In Capital Historical Data

The historical data trend for Medipost Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Additional Paid-In Capital Chart

Medipost Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

118.32

109.73

117.85

133.85

122.51

Medipost Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															121.34	122.16	158.82	211.76	207.42

Medipost Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Medipost Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Medipost Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (Medipost Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

078160:Korea

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines